Current studies into retatruptide peptide reveal significant potential for addressing weight and type 2 diabetes mellitus. The molecule, a dual stimulator of glucagon-like peptide-1 and GIP, seems to offer enhanced weight loss and glucose management in contrast to existing medications. Additional